Read all posts

New Class of Cholesterol Drugs Shows Promise For Heart Disease

Experimental drugs intended to lower cholesterol may also significantly reduce the risk of heart attacks and strokes, according to two new studies. New research published in The New England Journal of Medicine show that a new class of cholesterol drugs, called PCSK9 inhibitors, may not just lower levels of bad cholesterol, but may also reduce the likelihood of adverse heart events.

Read the article on Time

Dr. Sears Comments:

Dr. Barry Sears

Lowering cholesterol levels doesn’t necessarily lower cardiovascular mortality. However, lowering the AA/EPA ratio in the blood does reduce cardiovascular events. This is why the Japanese have the same cholesterol levels as Americans but seven times lower death rates from heart disease. Their AA/EPA ratio is seven times lower.

Leave a Reply

Your email address will not be published. Required fields are marked *